PEIJIA-B (09996) achieved a revenue of approximately 3.5-3.6 billion yuan in the first half of the year, representing a year-on-year growth of about 16.2%-19.5%.
Peijia Medical-B (09996) announced that the group's revenue in the first half of 2025 is approximately 3.5-3.6 billion...
PEIJIA-B (09996) announced that the group's revenue in the first half of 2025 was approximately 3.5 billion to 3.6 billion yuan, an increase of about 16.2% to 19.5% year-on-year.
The announcement stated that the main drivers of the continued revenue growth are as follows:
-The group's market share in the Transcatheter Aortic Valve Replacement (TAVR) market in China further expanding and the product mix tilting towards newly launched high-end products; and the strong performance of key neurointerventional products, such as deepening market penetration of existing advantages products such as DCwire microguidewire, Tethys AS thrombus aspiration catheter, and Fastunnel delivery type balloon dilatation catheter; and the successful launch of the newly approved YonFlow blood flow-guided mesh stent.
During the reporting period, the group's comprehensive TAVR portfolio (including TaurusOne, TaurusElite, and the newly launched TaurusMax) expanded to over 70 new healthcare institutions, covering a total of over 720 healthcare institutions as of June 30, 2025. During the reporting period, the total number of TAVR implants exceeded 2,050 units, an increase of about 18.8% year-on-year.
Related Articles

HK Stock Market Move | Rare-Earth (06680) stock surged over 7% in the afternoon. The company plans to release its financial performance on the 19th of this month, expecting a maximum growth in mid-term net profit of up to 180%.

Tianfeng: The cost and energy advantages of natural alkaline method are prominent, focus on listed companies with cost advantages.

HK Stock Market Move | Chip stocks are generally rising, with SMIC and Huahong set to disclose their second quarter financial reports soon. Institutions say the trend towards self-reliance and controllability is irreversible.
HK Stock Market Move | Rare-Earth (06680) stock surged over 7% in the afternoon. The company plans to release its financial performance on the 19th of this month, expecting a maximum growth in mid-term net profit of up to 180%.

Tianfeng: The cost and energy advantages of natural alkaline method are prominent, focus on listed companies with cost advantages.

HK Stock Market Move | Chip stocks are generally rising, with SMIC and Huahong set to disclose their second quarter financial reports soon. Institutions say the trend towards self-reliance and controllability is irreversible.

RECOMMEND

VSTECS Holdings: Long-Term Growth Potential with Strong Supplier Network and Strategic Positioning
06/08/2025

China to Implement Temporary Tariff Rates on Certain Commodities Starting December 1
06/08/2025

Property Management Firms Poised to Benefit from Urban Renewal, Asset Revitalization, and Expanded Lifestyle Services
06/08/2025